IP Library Granted Patent US 10,398,859
Granted Patent B2
US 10,398,859 · App. 14/798,221 · Granted Sep 3, 2019

Nasal delivery devices

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,398,859
App. No.
14/798,221
Granted
Sep 3, 2019
Kind
B2
Abstract

A nasal delivery device for and method of delivering substance to a nasal cavity of a subject, the delivery device comprising: a container-receiving unit comprising a container chamber for receiving a substance-containing container which contains substance to be delivered to the nasal cavity of the subject, the container chamber including an inlet and an outlet; a nosepiece unit including a nosepiece for fitting to a nasal cavity of the subject and being in fluid communication with the outlet of the container chamber; a mouthpiece unit including a mouthpiece in fluid communication with the inlet of the container chamber and through which the subject in use exhales, such as to entrain substance from the container and deliver the same through the nosepiece; and moisture-mitigation means for mitigating an effect of moisture in an exhaled breath on the entrainment of substance from the container, which means are provided, for example, by providing the container in a replaceable container-containing member, by a pressure-sensitive valve which normally closes the fluid connection between the container chamber and the mouthpiece, and a temperature regulator upstream of the container chamber.

Claims (8)

1. A nasal delivery device for delivering a substance to a nasal cavity of a subject, the delivery device comprising:

a removable nosepiece adapted unit including a nosepiece for fitting to the nasal cavity of the subject and a container-containing member which contains a substance-containing container containing substance to be delivered to the nasal cavity of the subject, wherein the container-containing member includes a flow passage in which the substance-containing container is disposed so as to be rotatable therewithin, and first and second apertures in a lateral wall thereof;

a container-receiving unit comprising a container chamber for receiving the container-containing member, wherein the container chamber includes an inlet and an outlet which is in fluid communication with the nosepiece, wherein the outlet of the container chamber receives the container-containing member and the container-containing member is a sealing fit in the container chamber;

a mouthpiece unit including a mouthpiece in fluid communication with the inlet of the container chamber and through which the subject in use exhales so as to deliver an exhalation flow through the mouthpiece and the flow passage of the container-containing member and entrain substance from the substance-containing container and deliver the same through the nosepiece; and

a container-opening mechanism which is configured to open the substance-containing container when the substance-containing container is disposed in the container-containing member, wherein the container-opening mechanism comprises first and second piercing elements which are arranged to pass through the first and second apertures in the lateral wall of the container-containing member only when the container-containing member is sealingly fitted in the container chamber.

2. The delivery device of claim 1 , wherein the inlet provides a flow restriction to an exhalation flow as delivered therethrough.

3. The delivery device of claim 2 , wherein the inlet forms a seat on which a first end of the substance-containing container is seated prior to delivery of the exhalation flow through the flow passage.

4. The delivery device of claim 1 , wherein the substance-containing container is a capsule containing a powdered substance.

Assignments (11)
RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT REEL/FRAME 71337/0132 Recorded Mar 17, 2026
From: OAKTREE FUND ADMINISTRATION, LLC
To: OPTINOSE, INC.
Reel/Frame 075101/0804 →
PATENT SECURITY AGREEMENT Recorded Mar 16, 2026
From: OPTINOSE, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
Reel/Frame 075111/0018 →
SECURITY INTEREST Recorded May 22, 2025
From: OPTINOSE, INC.
To: OAKTREE FUND ADMINISTRATION, LLC
Reel/Frame 071337/0132 →
RELEASE OF SECURITY INTEREST Recorded May 21, 2025
From: BIOPHARMA CREDIT PLC, AS COLLATERAL AGENT
To: OPTINOSE INC.
Reel/Frame 071547/0979 →
CHANGE OF ADDRESS Recorded Jan 7, 2025
From: OPTINOSE, INC.
To: OPTINOSE, INC.
Reel/Frame 069834/0012 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 1, 2022
From: DJUPESLAND, PER GISLE; HAFNER, RODERICK PETER; SHELDRAKE, COLIN DAVID
To: OPTINOSE AS
Reel/Frame 061611/0883 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 27, 2022
From: OPTINOSE AS
To: OPTINOSE INC
Reel/Frame 061546/0424 →
SECURITY INTEREST Recorded Sep 13, 2019
From: OPTINOSE AS
To: BIOPHARMA CREDIT PLC, AS COLLATERAL AGENT
Reel/Frame 050371/0913 →
RELEASE OF SECURITY AGREEMENT RECORDED AT REEL 044976 FRAME 0505 Recorded Sep 13, 2019
From: ATHYRIUM OPPORTUNITIES III ACQUISITION LP
To: OPTINOSE AS
Reel/Frame 050371/0894 →
SECURITY INTEREST Recorded Dec 29, 2017
From: OPTINOSE AS
To: ATHYRIUM OPPORTUNITIES III ACQUISITION LP
Reel/Frame 044976/0505 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 14, 2017
From: DJUPESLAND, PER GISLE; HAFNER, RODERICK PETER; SHELDRAKE, COLIN DAVID
To: OPTINOSE AS
Reel/Frame 042709/0425 →